- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Pharma companies in Europe push for US-level drug prices | ||
| Do | AstraZeneca enters $200m AI cancer pact with Tempus and Pathos | ||
| Do | Repertoire and Genentech to develop autoimmune disease therapies | ||
| Do | Biogen's Friedreich's ataxia treatment authorised in UK | ||
| Mi | Eli Lilly sues Mochi Health and others for 'deceptive' tirzepatide marketing | ||
| Mi | Veraxa to go public in $1.6bn SPAC deal with Voyager | ||
| Mi | Synthetic hormones and the future of contraception | ||
| Mi | EditCo Bio secures access to Promega's technologies in licensing deal | ||
| Mi | FDA layoffs and priority review voucher programme's lapse disrupt rare disease pipeline | ||
| Mi | Boehringer to expand oncology presence with $572m Tessellate Bio deal | ||
| Mi | ConcertAI and Bayer to boost precision oncology with AI and ML insights | ||
| Mi | TNF and Renova Health use AI to identify patients for GLP-1 treatments | ||
| Di | First two medicinal products to undergo EU joint clinical assessments announced | ||
| Di | FSO vs FSP: One CRO highlights key considerations for your decision | ||
| Di | Regeneron partners with Fujifilm to broaden manufacturing capacity | ||
| Di | Spotlight on Hepatitis B: New report examines the disease's clinical trial landscape in 2025 | ||
| Di | DAAN Biotherapeutics and GC Cell agree on CAR-T, CAR-NK therapies | ||
| Di | KKR offers $1.2bn to buy Swedish life sciences group Biotage | ||
| Di | Roche announces $50bn US investment in pharma and diagnostics | ||
| Mo | FDA grants breakthrough status to uniQure's Huntington's disease therapy | ||
| Mo | UK's MHRA authorises GSK's Blenrep for multiple myeloma treatment | ||
| Mo | Sanofi and Regeneron's dupilumab approved by FDA for urticaria | ||
| 18.04. | Eli Lilly and BigHat Biosciences ink AI antibody discovery deal | ||
| 17.04. | Eli Lilly's shares up as oral GLP-1RA scores in first Phase III trial | ||
| 17.04. | FDA to review Regeneron's sBLA for aflibercept injection 8mg |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
